NEW YORK (GenomeWeb) – Sialix said this week that it has raised an additional $2 million as part of its Series B round, bringing the total raised to $6 million.
Biognosys this week named Patrick Plewman as its new CEO, taking over from Oliver Rinner, who is now the company's chief scientific officer.
Alex Bateman is joining the European Bioinformatics Institute as head of protein sequence resources, replacing Rolf Apweiler.
Sialix this week appointed Norrie Russell president and CEO – a newly established full-time position at the company.
The company, which has licensed intellectual property related to use of the auto-antibodies from UCSD, aims to develop the diagnostics first as CLIA-based tests and ultimately in a microarray format available to physicians.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.